Mitchell Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celsius Holdings
CELH
|
+$6.09M |
| 2 |
Robinhood
HOOD
|
+$5.72M |
| 3 |
Elevance Health
ELV
|
+$4.36M |
| 4 |
Medpace
MEDP
|
+$3.42M |
| 5 |
Eli Lilly
LLY
|
+$3.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$5.68M |
| 2 |
NVIDIA
NVDA
|
+$5.08M |
| 3 |
Corcept Therapeutics
CORT
|
+$4.61M |
| 4 |
Duolingo
DUOL
|
+$4.59M |
| 5 |
Veeva Systems
VEEV
|
+$3.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.67% |
| 2 | Financials | 12.76% |
| 3 | Communication Services | 10.68% |
| 4 | Consumer Discretionary | 9.23% |
| 5 | Healthcare | 6.42% |
Similar funds
Mitchell Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Mitchell Capital Management held 139 positions worth $559M, down 4.2% from $584M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Mitchell Capital Management withdrew a net $27.6M in Q4 2025, closing 22 positions and reducing 59 holdings. Its most notable exit was Tempus AI, an estimated $5.68M position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 42% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Mitchell Capital Management opened a new position in Celsius Holdings worth $5.53M.
- Mitchell Capital Management's largest Q4 2025 buy was Celsius Holdings: 120,850 shares worth $5.53M.
- Mitchell Capital Management added most to Eli Lilly in Q4 2025, an estimated $3.02M increase.
- Mitchell Capital Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $5.08M.
- Mitchell Capital Management fully exited Tempus AI in Q4 2025, selling an estimated $5.68M.
- Mitchell Capital Management's ten largest holdings make up 45% of its $559M portfolio in Q4 2025.
- Mitchell Capital Management opened 13 new positions and closed 22 in Q4 2025.
- Mitchell Capital Management's portfolio value fell 4.2% quarter-over-quarter to $559M.
Based on Mitchell Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.